Last reviewed · How we verify
Clesidren (epomediol)
Clesidren (generic name: epomediol) is a epomediol drug. It is currently in unknown development.
Clesidren works by binding to a specific target and altering its activity.
Clesidren, also known as Epomediol, is a synthetic terpenoid with choleretic effects. It is used in the symptomatic treatment of itching due to intrahepatic cholestasis of pregnancy.
At a glance
| Generic name | epomediol |
|---|---|
| Drug class | epomediol |
| Therapeutic area | Other |
| Phase | unknown |
Mechanism of action
Imagine your body's cells have locks on them, and the key to opening those locks is a specific shape. Clesidren is like a key that fits into those locks, changing how the cells work. This can help to treat certain conditions, but more research is needed to understand exactly how it works.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Clesidren CI brief — competitive landscape report
- Clesidren updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Clesidren
What is Clesidren?
How does Clesidren work?
What is the generic name of Clesidren?
What drug class is Clesidren in?
What development phase is Clesidren in?
Related
- Drug class: All epomediol drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing